AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Stryker has adjusted its 2025 profit outlook to between 9.5%-10%, up from 8.5%-9.5%, amid strong growth in its medical surgery and neurotechnology unit.

The FDA has approved SetPoint Medical’s neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis.

RFK Jr's statewide tour promoting his Make America Healthy Again (MAHA) agenda has been called “performative” by a US health consultancy.

AdvaMed has praised the CMS' plans to establish a framework to simplify the exchange of healthcare data between patients and providers.

Medical device database EUDAMED is viewed by the European Commission as an integral part of the EU MDR and EU IVDR’s implementation.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.

GE HealthCare and Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.

AngioDynamics has enrolled the first subject in the AMBITION BTK trial designed to assess the Auryon Atherectomy System.

ALZpath’s pTau217 antibody is drawing significant attention at this year’s Alzheimer's Association International Conference (AAIC), taking place in Toronto, Canada, from 27-31 July. The biomarker ...

Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter in patients with mild to moderate ...